Cargando…
The landscape of pharmacogenetic testing in a US managed care population
PURPOSE: Little is known about how many insured patients receive pharmacogenetic testing. We describe trends of single-gene pharmacogenetic testing in a US managed care population, and demographic and clinical characteristics of patients who received a test. METHODS: We leveraged a random sample of...
Autores principales: | Anderson, Heather D., Crooks, Kristy R., Kao, David P., Aquilante, Christina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332417/ https://www.ncbi.nlm.nih.gov/pubmed/32291400 http://dx.doi.org/10.1038/s41436-020-0788-3 |
Ejemplares similares
-
Pharmacogenetic testing among patients with depression in a US managed care population
por: Anderson, Heather D., et al.
Publicado: (2022) -
The Current Landscape of Marijuana and Pharmacogenetics
por: Rambaran, Kerry Anne, et al.
Publicado: (2017) -
Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing
por: Haga, Susanne B., et al.
Publicado: (2011) -
The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021) -
Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database
por: Bianchini, Monica L., et al.
Publicado: (2023)